All In Biotech

Drug Trial Radar · NCT07015190

Neoadjuvant Darovasertib in Primary Uveal Melanoma

A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in Subjects With Primary Non-metastatic Uveal Melanoma (OptimUM-10)

Last checked: Nov 20, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 520 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

520

Planned (sponsor's estimate)

Start

Jan 25, 2026

Primary completion

Oct 2030

Study completion Mar 2031

Sponsor

Lead sponsor
IDEAYA BiosciencesIndustry
Sponsor type
Industry
First posted
Jun 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (OptimUM-10)

Conditions

  • Uveal Melanoma

Interventions

  • DarovasertibDrug

    Dosed orally, twice daily (28-day/ cycle

  • Primary Local TherapyProcedure

    Plaque Brachytherapy or Enucleation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cohort 1: To demonstrate that the proportion of subjects with vision loss is lower for subjects in the Treatment Arm vs the Control ArmTime frame: Approximately 3 years
  2. Cohort 2: To demonstrate the ability to salvage the eye and prevent enucleation in the Treatment ArmTime frame: Approximately 2 years

Locations

94 sites in 21 countries. Site status is shown where the registry gives one.

  • Mayo Clinic Scottsdale - PPDS

    Scottsdale, Arizona · Recruiting

  • UCSD Moores Cancer Center

    La Jolla, California · Not yet recruiting

  • Jules Stein Eye Institute

    Los Angeles, California · Not yet recruiting

  • USC Norris Comprehensive Cancer Center

    Los Angeles, California · Not yet recruiting

  • University of California Irvine Medical Center

    Orange, California · Not yet recruiting

  • Stanford Comprehensive Cancer Center

    Palo Alto, California · Recruiting

  • Kaiser Permanente-Riverside Medical Center

    Riverside, California · Recruiting

  • UCSF Wayne and Gladys Valley Center for Vision

    San Francisco, California · Not yet recruiting

  • University of Colorado Hospital

    Aurora, Colorado · Recruiting

  • The Melanoma and Skin Cancer Institute

    Englewood, Colorado · Not yet recruiting

  • Mayo Clinic Jacksonville

    Jacksonville, Florida · Recruiting

  • USF Health Eye Institute

    Tampa, Florida · Not yet recruiting

  • Moffit Cancer Center

    Tampa, Florida · Not yet recruiting

  • Wilmer Eye Institute

    Baltimore, Maryland · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Not yet recruiting

  • W Kellogg Eye Center

    Ann Arbor, Michigan · Not yet recruiting

  • The Cancer and Hematology Centers of West Michigan (CHCWM)

    Grand Rapids, Michigan · Recruiting

  • Mayo Clinic - PPDS

    Rochester, Minnesota · Recruiting

  • TIERING Percentiles

    Omaha, Nebraska · Not yet recruiting

  • Herbert Irving Comprehensive Cancer Center

    New York, New York · Recruiting

  • Memorial Sloan Kettering Cancer Center - 1275 York Ave

    New York, New York · Not yet recruiting

  • Northwell Health Cancer Institute

    New York, New York · Not yet recruiting

  • Cole Eye Institute-9500 Euclid Ave

    Cleveland, Ohio · Not yet recruiting

  • Ohio State Eye and Ear Institute

    Columbus, Ohio · Not yet recruiting

  • Retina Consultants of Oklahoma

    Oklahoma City, Oklahoma · Not yet recruiting

  • Jefferson Health Honickman Center

    Philadelphia, Pennsylvania · Not yet recruiting

  • UPMC Hillman Cancer Center

    Pittsburgh, Pennsylvania · Not yet recruiting

  • SCRI Oncology Partners

    Nashville, Tennessee · Recruiting

  • Vanderbilt Eye Institute

    Nashville, Tennessee · Not yet recruiting

  • Austin Retina Associates - Central

    Austin, Texas · Recruiting

  • Texas Retina Associates - Dallas

    Dallas, Texas · Recruiting

  • University of Texas Southwestern Medical Center-5323 Harry Hines Blvd

    Dallas, Texas · Recruiting

  • Retina Consultants of Texas - (Houston)

    Houston, Texas · Not yet recruiting

  • Augusta Health, Center for Cancer and Blood Disorders

    Fishersville, Virginia · Not yet recruiting

  • University of Wisconsin Health

    Madison, Wisconsin · Not yet recruiting

  • The Crown Princess Mary Cancer Centre (Westmead Hospital), NSW 214

    Westmead, Australia · Not yet recruiting

  • Gallipoli Medical Research Foundation

    Greenslopes, Queensland, Australia · Not yet recruiting

  • The Queen Elizabeth Hospital

    Woodville South, South Australia, Australia · Not yet recruiting

  • The Alfred Hospital

    Melbourne, Victoria, Australia · Not yet recruiting

  • LKH-Universitätsklinikum Graz

    Graz, Austria · Not yet recruiting

Showing 40 of 94 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.